NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

南美的介入心臟病學市場:到2030年的預測

Latin America Interventional Cardiology Market Outlook 2030

出版商 Research Nester 商品編碼 980797
出版日期 內容資訊 英文 346 Pages
商品交期: 最快1-2個工作天內
價格
南美的介入心臟病學市場:到2030年的預測 Latin America Interventional Cardiology Market Outlook 2030
出版日期: 2020年12月10日內容資訊: 英文 346 Pages
簡介

南美的介入心臟病學的市場規模,2019年約7億美金,預計從2021年到2030年的預測期間以8.48%的年複合成長率成長。由於可支配所得增加,人們對醫療進行許多投資。由於國內的心血管疾病的盛行率高漲,現在巴西佔該市場最大的佔有率,實施的介入心臟病學的數量也增加。

本報告提供南美的介入心臟病學市場的相關調查,市場規模和預測,趨勢和機會,成長及阻礙因素,各設備、用途、終端用戶、各國市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 市場定義
  • 市場區隔
  • 產品概要

第2章 前提條件、簡稱

第3章 調查手法

  • 調查流程
  • 2次調查
  • 1次調查
  • 市場規模的估計

第4章 摘要整理

第5章 法規情形

第6章 主要市場機會

  • 地理性的機會
  • 策略性的競爭機會

第7章 風險分析

  • 需求風險分析
  • 供給風險分析

第8章 Covid-19的影響分析

第9章 心血管障礙的流行病學分析

第10章 市場動態分析

  • 成長要素
  • 阻礙因素/課題
  • 主要趨勢

第11章 價格分析

第12章 市場預測

  • 市場規模與預測,2018-2030f
    • 各銷售額
    • 各交易量
  • 各設備
    • 血管新生球囊(2015-2030f)
      • 傳統/一般型球囊
      • 球囊的切斷和評分
      • 藥物釋放型性球囊
    • 血管成形術支架(2015-2030f)
      • 藥物釋放型性支架
      • 傳統金屬支架
      • 生物可吸收支架
    • 導管(2015-2030f)
      • 診斷導管
      • 血管造影術導管
      • IVUSOCT–導管
      • 引導管
    • 斑塊改善設備(2015-2030f)
      • 血栓摘出設備
      • 旋切術設備
    • 血液循環動態改善設備(2015-2030f)
      • 栓塞保護設備
      • 慢性完全閉塞設備
    • 導管導引線(2015-2030f)
    • 其他(血管閉合設備等)(2015-2030f)
  • 各用途(2015-2030f)
    • 冠狀動脈疾病
    • 週邊動脈疾病
    • 神經血管疾病
    • 其他
  • 各終端用戶(2015-2030f)
    • 導管檢驗室
    • 醫院
    • 診所
    • 門診病人手術中心
  • 各國(2015-2030f)
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 厄瓜多
    • 委內瑞拉
    • 多明尼加共和國
    • 瓜地馬拉
    • 巴拿馬
    • 哥斯大黎加
    • 烏拉圭
    • 其他南美國家

第13章 競爭考察

  • 市場佔有率分析
  • 每個地區的主要製造商的評估
  • 地區市場競爭評估
    • ABBOTT
    • BOSTON SCIENTIFIC CORPORATION
    • MERIT MEDICAL
    • BIOSENSORS INTERNATIONAL GROUP, LTD.
    • TERUMO EUROPE NV
    • MEDTRONIC
    • CORDIS
    • BIOTRONIK
    • 其他的市場企業

第14章 分析師檢討

目錄

Interventional cardiology market comprises of products that are used in catheter-based diagnosis & treatments of various cardiac disorders under coronary artery disease, vascular disease and acquired structural heart disease. In 2019, the Latin America Interventional Cardiology Market accounted for a market value of around USD 700 million and is expected to grow at a CAGR of 8.48% over the forecast period of 2021-2030. People are investing more on medical care owing to the growing disposable income. The largest share of the Latin American interventional cardiology market is currently owned by Brazil, owing to the increasingly growing prevalence of cardiovascular diseases in the nation, which has also led to an increase in the number of interventional cardiology procedures being implemented.

The Latin America interventional cardiology market consists of various segments that are segmented by devices, application and end user. The market is further segmented by devices into angioplasty balloons, angioplasty stents, catheters, plaque modification devices, hemodynamic flow alteration devices, guidewires, and others, out of which, angioplasty balloons accounted for a market share of around 30% in 2019. The angioplasty balloons consist of old/normal balloons, cutting and scoring balloons, and drug-eluting balloons. Angioplasty balloons are highly used in angioplasty procedures to restore blood flow into the heart. A surge in their demand has been generated by their increasing application in cardiology.

On the basis of application, the market is segmented into coronary artery disease, peripheral artery disease, neurovascular disease and others, out of which, coronary artery disease accounted for a market share of around 45% in 2019 and expected to grow by a significant CAGR over the forecast period. The most prevalent form of heart disease is known to be coronary artery disease. It happens when the arteries that supply blood to the heart gets a blockage. Furthermore, the growing prevalence of the disease has generated an increase in demand for innovative devices and treatments which can reduce complications and improve the quality of life. In addition, risk factors for cardiovascular diseases are extremely prevalent in Latin America, which is also projected to drive the growth of Latin America interventional cardiology market.

The advancements in technology in the healthcare sector and increasing research and development investments have created an upsurge in the growth of the Latin America interventional cardiology market. The rapidly increasing prevalence of cardiovascular diseases is consistently attracting various market players in the interventional cardiology market who are incorporating multiple research and development activities coupled with different technologies to improve their product portfolio. Additionally, various market players are making huge investments to reduce the cost of the product so that key application-based end markets can use it. This factor is projected to drive the growth of the market in the upcoming years.

However, lack of skilled cardiovascular surgeons to perform interventional cardiology procedures and high risk of infection in patients after the procedure are estimated to act as barriers to the growth of the Latin America interventional cardiology market during the forecast period.

Some of the affluent leaders in the Latin America Interventional Cardiology Market are: Boston Scientific Corporation, Merit Medical Systems, Biosensors International Group, Ltd., Terumo Europe NV, Medtronic, Cardinal Health (Cordis), BIOTRONIK SE & Co KG, and others.

Table of Contents

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Segmentation
  • 1.3. Product Overview

2. Assumptions And Acronyms

3. Research Methodology

  • 3.1. Research Process
  • 3.2. Secondary Research
  • 3.3. Primary Research
  • 3.4. Market Size Estimation

4. Executive Summary- Latam Interventional Cardiology Market

5. Regulatory Landscape

6. Key Market Opportunities

  • 6.1. Geographic Opportunities
  • 6.2. Strategic Competitive Opportunities

7. Risk Analysis

  • 7.1. Demand Risk Analysis
  • 7.2. Supply Risk Analysis

8. Impact Analysis Of Covid-19 On The Market

9. Epidemiology Analysis Of Cardiovascular Disorders

10. Analysis Of Market Dynamics

  • 10.1. Growth Drivers
  • 10.2. Restraints/Challenges
  • 10.3. Key Trends

11. Pricing Analysis

12. LATAM Interventional Cardiology Market Outlook

  • 12.1. Market Size And Forecast, 2018-2030f
    • 12.1.1. By Value (USD Million)
    • 12.1.2. By Volume (Million Units)
      • 12.1.2.1. Latin America Interventional Cardiology Market, 2015-2030f (USD Million & Million Units)
      • 12.1.2.1.1. Market Overview
      • 12.1.2.1.2. Assessment Of Macroeconomic Factors Of Countries
      • 12.1.2.1.3. Regional Growth Prospects
      • 12.1.2.1.4. List Of Key Players
      • 12.1.2.1.5. By Market Segmentation
  • Device (Market Size & Market Share)
    • Angioplasty Balloons, 2015-2030f (USD Million & Million Units)
      • Old/Normal Balloons, 2015-2030f (USD Million & Million Units)
      • Cutting And Scoring Balloons, 2015-2030f (USD Million & Million Units)
      • Drug-Eluting Balloons, 2015-2030f (USD Million & Million Units)
    • Angioplasty Stents, 2015-2030f (USD Million & Million Units)
      • Drug-Eluting Stents, 2015-2030f (USD Million & Million Units)
      • Bare-Metal Stents, 2015-2030f (USD Million & Million Units)
      • Bioabsorbable Stents, 2015-2030f (USD Million & Million Units)
    • Catheters, 2015-2030f (USD Million & Million Units)
      • Diagnostic Catheters, 2015-2030f (USD Million & Million Units)
      • Angiography Catheters, 2015-2030f (USD Million & Million Units)
      • Ivus/Oct Catheters, 2015-2030f (USD Million & Million Units)
      • Guiding Catheters, 2015-2030f (USD Million & Million Units)
    • Plaque Modification Devices, 2015-2030f (USD Million & Million Units)
      • Thrombectomy Devices, 2015-2030f (USD Million & Million Units)
      • Atherectomy Devices, 2015-2030f (USD Million & Million Units)
    • Hemodynamic Flow Alteration Devices, 2015-2030f (USD Million & Million Units)
      • Embolic Protection Devices, 2015-2030f (USD Million & Million Units)
      • Chronic Total Occlusion Devices, 2015-2030f (USD Million & Million Units)
    • Guidewires, 2015-2030f (USD Million & Million Units)
    • Others (Vascular Closure Devices, Etc.), 2015-2030f (USD Million & Million Units)
  • Application (Market Size & Market Share)
    • Coronary Artery Disease, 2015-2030f (USD Million & Million Units)
    • Peripheral Artery Disease, 2015-2030f (USD Million & Million Units)
    • Neurovascular Disease, 2015-2030f (USD Million & Million Units)
    • Others, 2015-2030f (USD Million & Million Units)
  • End-Users (Market Size & Market Share)
    • Catheterization Laboratories, 2015-2030f (USD Million & Million Units)
    • Hospitals, 2015-2030f (USD Million & Million Units)
    • Clinics, 2015-2030f (USD Million & Million Units)
    • Ambulatory Surgical Centers, 2015-2030f (USD Million & Million Units)
  • Country
    • Brazil, 2015-2030f (USD Million & Million Units)
  • Device (Market Size & Market Share)
  • Application (Market Size & Market Share)
  • End-Users (Market Size & Market Share)
    • Mexico, 2015-2030f (USD Million & Million Units)
  • Device (Market Size & Market Share)
  • Application (Market Size & Market Share)
  • End-Users (Market Size & Market Share)
    • Argentina, 2015-2030f (USD Million & Million Units)
  • Device (Market Size & Market Share)
  • Application (Market Size & Market Share)
  • End-Users (Market Size & Market Share)
    • Colombia, 2015-2030f (USD Million & Million Units)
  • Device (Market Size & Market Share)
  • Application (Market Size & Market Share)
  • End-Users (Market Size & Market Share)
    • Chile, 2015-2030f (USD Million & Million Units)
  • Device (Market Size & Market Share)
  • Application (Market Size & Market Share)
  • End-Users (Market Size & Market Share)
    • Peru, 2015-2030f (USD Million & Million Units)
  • Device (Market Size & Market Share)
  • Application (Market Size & Market Share)
  • End-Users (Market Size & Market Share)
    • Ecuador, 2015-2030f (USD Million & Million Units)
  • Device (Market Size & Market Share)
  • Application (Market Size & Market Share)
  • End-Users (Market Size & Market Share)
    • Venezuela, 2015-2030f (USD Million & Million Units)
  • Device (Market Size & Market Share)
  • Application (Market Size & Market Share)
  • End-Users (Market Size & Market Share)
    • Dominican Republic, 2015-2030f (USD Million & Million Units)
  • Device (Market Size & Market Share)
  • Application (Market Size & Market Share)
  • End-Users (Market Size & Market Share)
    • Guatemala, 2015-2030f (USD Million & Million Units)
  • Device (Market Size & Market Share)
  • Application (Market Size & Market Share)
  • End-Users (Market Size & Market Share)
    • Panama, 2015-2030f (USD Million & Million Units)
  • Device (Market Size & Market Share)
  • Application (Market Size & Market Share)
  • End-Users (Market Size & Market Share)
    • Costa Rica, 2015-2030f (USD Million & Million Units)
  • Device (Market Size & Market Share)
  • Application (Market Size & Market Share)
  • End-Users (Market Size & Market Share)
    • Uruguay, 2015-2030f (USD Million & Million Units)
  • Device (Market Size & Market Share)
  • Application (Market Size & Market Share)
  • End-Users (Market Size & Market Share)
    • Rest Of Latin America, 2015-2030f (USD Million & Million Units)
  • Device (Market Size & Market Share)
  • Application (Market Size & Market Share)
  • End-Users (Market Size & Market Share)

13. Competitive Insights

  • 13.1. Market Share Analysis
  • 13.2. Assessment Of The Region-Wise Key Manufacturers
  • 13.3. Evaluation Of The Regional Competitors Of The Market
    • 13.3.1. ABBOTT
      • 13.3.1.1. Business Overview
      • 13.3.1.2. Products Offered
      • 13.3.1.3. Key Clients & Partners
      • 13.3.1.4. Financials
      • 13.3.1.5. Business Strategy
      • 13.3.1.6. Recent News & Developments
      • 13.3.1.7. Key Performance Indicators
      • 13.3.1.8. Geographical Presence
    • 13.3.2. BOSTON SCIENTIFIC CORPORATION
    • 13.3.3. MERIT MEDICAL
    • 13.3.4. BIOSENSORS INTERNATIONAL GROUP, LTD.
    • 13.3.5. TERUMO EUROPE NV
    • 13.3.6. MEDTRONIC
    • 13.3.7. CORDIS
    • 13.3.8. BIOTRONIK
    • 13.3.9. Other Market Players

14. Analyst Review